India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9. Director (Government and Regulatory Affairs) at SII Prakash Kumar Singh recently had written to the health ministry urging it to include Covovax in the national COVID-19 vaccination drive for 12 years and above.
